US HB4393 | 2019-2020 | 116th Congress

Status

Spectrum: Strong Partisan Bill (Democrat 37-3)
Status: Introduced on September 18 2019 - 25% progression, died in committee
Action: 2019-09-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Allows state Medicaid programs to cover DNA sequencing clinical services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to a pediatric intensive care unit and seen by a medical specialist for a chronic or undiagnosed disease, and (2) are suspected by a medical specialist to have a pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services. Additionally, the National Academy of Medicine must study the effects of genetic and genomic testing and ways to expand health insurance coverage of such services, including under Medicare and Medicaid.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Advancing Access to Precision Medicine Act

Sponsors


History

DateChamberAction
2019-09-19HouseReferred to the Subcommittee on Health.
2019-09-18HouseReferred to the House Committee on Energy and Commerce.
2019-09-18HouseIntroduced in House

Same As/Similar To

SB3116 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)

Subjects


US Congress State Sources


Bill Comments

feedback